Who is sponsoring NCT06035445?

NCT06035445 is sponsored by Emory University.

What drugs are being tested in NCT06035445?

Interventions in NCT06035445: In-person adolescent-friendly service (iPAS) intervention, mHealth (InTSHA) intervention, Standard of Care.

What condition does NCT06035445 study?

NCT06035445 studies Human Immunodeficiency Virus, HIV.

Is NCT06035445 still recruiting?

NCT06035445 is currently active, enrolled. Last updated 9 March 2026.

Last reviewed 2026-03-09 · How we verify

NCT06035445: InTSHA VIP

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Support for Adolescents Living With HIV in South Africa

Active, enrolled NA Last updated 9 March 2026

What this trial tests

NA trial testing In-person adolescent-friendly service (iPAS) intervention in Human Immunodeficiency Virus in 570 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline

2 February 2024

Primary endpoint
31 December 2027

31 December 2027

Quick facts

Lead sponsor	Emory University
Phase	NA
Status	Active, enrolled
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	supportive care
Enrollment	570
Start date	2 February 2024
Primary completion	31 December 2027
Estimated completion	31 December 2027
Sites	1 location across South Africa

Drugs / interventions tested

In-person adolescent-friendly service (iPAS) intervention
mHealth (InTSHA) intervention
Standard of Care

Conditions studied

Human Immunodeficiency Virus — all drugs for Human Immunodeficiency Virus →
HIV — all drugs for HIV →

Sponsor

Emory University

Who can join

Adults 15 to 19, any sex, with Human Immunodeficiency Virus or HIV. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is a cluster randomized controlled trial determining the effectiveness of in-person or mHealth-based adolescent-friendly transition interventions compared to standard care on retention in care and viral suppression among adolescents living with HIV who have low transition readiness. Participants are adolescents living with HIV ages 15 to 19 years old in KwaZulu-Natal, South Africa.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Interactive Transition Support for Adolescents Living with HIV Comparing Virtual and In-person delivery (InTSHA VIP): a stepped-wedge, cluster-randomised trial in South Africa.
Magut F, Baisley K, Sibaya T, Upton J, et al · · 2026 · PMID 41618237 · DOI 10.1186/s12913-026-14070-8

Verify or expand the search:

Other recruiting trials for Human Immunodeficiency Virus

Currently open trials in the same condition.

NCT07530198 — HIV Therapeutic DNA Vaccine (ICVAX) Phase I Clinical Trial in Hong Kong · Phase 1 · recruiting
NCT06819176 — Lenacapavir Intensification to Disrupt HIV Reservoirs in Virologically Suppressed People With HIV Receiving Antiretrovir · Phase 1 · recruiting
NCT06408142 — Universal Test and Connect for HIV Service Delivery in South Africa · recruiting
NCT07101458 — The Eswatini PRISM Study on Adolescents Living With HIV · NA · recruiting
NCT06554223 — The SUSTAIN 2 Study - SUStained HIV Treatment for Adherence After Interruption in Care · NA · recruiting

Other Emory University trials

Trials by the same sponsor.

NCT06143345 — HIIT in Isolated IFG: A Proof-of-Concept Study · NA · withdrawn
NCT07189819 — Innovative Closed-loop Functional Electrical Stimulation Control System for Augmenting Post-stroke Gait · NA · not yet recruiting
NCT06451055 — Low-calorie Diet in Isolated Impaired Fasting Glucose · NA · not yet recruiting
NCT07405476 — Zanidatamab Before Surgery for the Treatment of HER2 Positive Colon and Rectal Cancer in Patients Planned for Curative I · Phase 2 · recruiting
NCT06708351 — Enhancing Cervical Cancer Screening and Treatment in Women Living With HIV in Kenya, the ENHANCE LINKAge Trial · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06035445 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Emory University
Last refreshed: 9 March 2026

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06035445.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing